These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 17721936)

  • 1. Sucrose acetate isobutyrate as an in situ forming system for sustained risperidone release.
    Lu Y; Yu Y; Tang X
    J Pharm Sci; 2007 Dec; 96(12):3252-62. PubMed ID: 17721936
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Rheological properties of sucrose acetate isobutyrate in situ gel].
    Lu YX; He HB; Cui Y; Tang X
    Yao Xue Xue Bao; 2007 Apr; 42(4):445-9. PubMed ID: 17633217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tracking the effect of microspheres size on the drug release from a microsphere/sucrose acetate isobutyrate (SAIB) hybrid depot in vitro and in vivo.
    Lin X; Wang J; Xu Y; Tang X; Chen J; Zhang Y; Zhang Y; Yang Z
    Drug Dev Ind Pharm; 2016 Sep; 42(9):1455-65. PubMed ID: 26790718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo evaluation of risperidone-SAIB in situ system as a sustained release delivery system in rats.
    Lu Y; Tang X; Cui Y; Zhang Y; Qin F; Lu X
    Eur J Pharm Biopharm; 2008 Feb; 68(2):422-9. PubMed ID: 17614267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Preparation and evaluation of risperidone-loaded microsphere/sucrose acetate isobutyrate in situ forming complex depot with double diffusion barriers].
    Lin X; Tang X; Xu YH; Zhang Y; Zhang Y; He HB
    Yao Xue Xue Bao; 2015 Jun; 50(6):775-82. PubMed ID: 26521452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Uniform Ultra-Small Microsphere/SAIB Hybrid Depot with Low Burst Release for Long-Term Continuous Drug Release.
    Lin X; Xu Y; Tang X; Zhang Y; Chen J; Zhang Y; He H; Yang Z
    Pharm Res; 2015 Nov; 32(11):3708-21. PubMed ID: 26077999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel risperidone-loaded SAIB-PLGA mixture matrix depot with a reduced burst release: effects of solvents and PLGA on drug release behaviors in vitro/in vivo.
    Lin X; Yang S; Gou J; Zhao M; Zhang Y; Qi N; He H; Cai C; Tang X; Guo P
    J Mater Sci Mater Med; 2012 Feb; 23(2):443-55. PubMed ID: 22170300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivery of radix ophiopogonis polysaccharide via sucrose acetateisobutyrate-based in situ forming systems alone or combined with itsmono-PEGylation.
    Wang L; Zheng X; Wu F; Shen L; Lin X; Feng Y
    Drug Deliv; 2018 Nov; 25(1):267-277. PubMed ID: 29334805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of the Antitumor Efficacy of Intratumoral Administration of Cucurbitacin Poly(Lactic-co-Glycolic Acid) Microspheres Incorporated in In Situ-Forming Sucrose Acetate Isobutyrate Depots.
    Wang JW; Xu JH; Li J; Zhao MH; Zhang HF; Liu DC; Zhou X; Xu H
    J Pharm Sci; 2016 Jan; 105(1):205-11. PubMed ID: 26566075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel in situ forming drug delivery system for controlled parenteral drug delivery.
    Kranz H; Bodmeier R
    Int J Pharm; 2007 Mar; 332(1-2):107-14. PubMed ID: 17084049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microsphere delivery of Risperidone as an alternative to combination therapy.
    D'Souza S; Faraj J; DeLuca P
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):631-9. PubMed ID: 23892159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long acting porous microparticle for pulmonary protein delivery.
    Kwon MJ; Bae JH; Kim JJ; Na K; Lee ES
    Int J Pharm; 2007 Mar; 333(1-2):5-9. PubMed ID: 17296275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sucrose Acetate Isobutyrate as an In situ Forming Implant for Sustained Release of Local Anesthetics.
    Li H; Xu Y; Tong Y; Dan Y; Zhou T; He J; Liu S; Zhu Y
    Curr Drug Deliv; 2019; 16(4):331-340. PubMed ID: 30451111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Injectable long-term control-released in situ gels of hydrochloric thiothixene for the treatment of schizophrenia: preparation, in vitro and in vivo evaluation.
    Xin C; Lihong W; Qiuyuan L; Hongzhuo L
    Int J Pharm; 2014 Jul; 469(1):23-30. PubMed ID: 24751344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Collagen-chondroitin sulfate-based PLLA-SAIB-coated rhBMP-2 delivery system for bone repair.
    Keskin DS; Tezcaner A; Korkusuz P; Korkusuz F; Hasirci V
    Biomaterials; 2005 Jun; 26(18):4023-34. PubMed ID: 15626448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biodegradable nanoparticles for protein delivery: analysis of preparation conditions on particle morphology and protein loading, activity and sustained release properties.
    Coleman J; Lowman A
    J Biomater Sci Polym Ed; 2012; 23(9):1129-51. PubMed ID: 21639993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained release hGH microsphere formulation produced by a novel supercritical fluid technology: in vivo studies.
    Jordan F; Naylor A; Kelly CA; Howdle SM; Lewis A; Illum L
    J Control Release; 2010 Jan; 141(2):153-60. PubMed ID: 19772878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained delivery of human growth hormone using a polyelectrolyte complex-loaded thermosensitive polyphosphazene hydrogel.
    Park MR; Chun C; Ahn SW; Ki MH; Cho CS; Song SC
    J Control Release; 2010 Nov; 147(3):359-67. PubMed ID: 20713099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preparation of Eudragit E100 microspheres by modified solvent evaporation method.
    Singh V; Chaudhary AK
    Acta Pol Pharm; 2011; 68(6):975-80. PubMed ID: 22125964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single processing step toward injectable sustained-release formulations of Triptorelin based on a novel degradable semi-solid polymer.
    Asmus LR; Kaufmann B; Melander L; Weiss T; Schwach G; Gurny R; Möller M
    Eur J Pharm Biopharm; 2012 Aug; 81(3):591-9. PubMed ID: 22561956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.